Literature DB >> 497088

Cimetidine: effect on pancreatic and biliary function in man.

D P Maudgal, D Lawrence, F M Sanderson, T C Northfield.   

Abstract

1 Pancreatic and biliary function were studied in eight patients taking oral cimetidine (1.6 g/day for 6 weeks) for endoscopically confirmed active peptic ulcer disease. 2 Postprandial jejunal tryptic activity and bile acid concentration were unchanged during cimetidine given for 1 and 6 weeks. 3 Postprandial gallbladder emptying was also unchanged. 4 Direct examination of postprandial upper jejunal aspirate for deconjugated bile acids was negative in all patients; but the more sensitive [14C]-glycocholate bile acid breath test showed a significant increase in breath 14CO2, indicating increased bacterial deconjugation of bile acids in the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 497088      PMCID: PMC1429788          DOI: 10.1111/j.1365-2125.1979.tb01006.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

1.  Effect of metiamide on the response to secretin and cholecystokinin in man.

Authors:  B Thjodleifsson; K G Wormsley
Journal:  Gut       Date:  1975-01       Impact factor: 23.059

2.  Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.

Authors:  W L Burland; W A Duncan; T Hesselbo; J G Mills; P C Sharpe; S J Haggie; J H Wyllie
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

3.  The effect of histamine (H2-) receptor blockade on vagally-induced gastric secretion in man.

Authors:  D C Carter; M Werner; J H Forrest; R C Heading; J Park; D J Shearman
Journal:  Scott Med J       Date:  1974-05       Impact factor: 0.729

4.  Breath test for altered bile-acid metabolism.

Authors:  H Fromm; A F Hofmann
Journal:  Lancet       Date:  1971-09-18       Impact factor: 79.321

5.  Intraluminal bile-salt deficiency in the pathogenesis of steatorrhoea.

Authors:  B W Badley; G M Murphy; I A Bouchier
Journal:  Lancet       Date:  1969-08-23       Impact factor: 79.321

6.  Metiamide, an H2-receptor blocker, as inhibitor of basal and meal-stimulated gastric acid secretion in patients with duodenal ulcer.

Authors:  M Mainardi; V Maxwell; R A Sturdevant; J I Isenberg
Journal:  N Engl J Med       Date:  1974-08-22       Impact factor: 91.245

7.  Letter: Reversal of metiamide-induced agranulocytosis during treatment with cimetidine.

Authors:  W L Burland; P C Sharpe; D G Colin-Jones; P R Turnbull; P Bowskill
Journal:  Lancet       Date:  1975-11-29       Impact factor: 79.321

8.  The effect of an H2-receptor antagonist on food-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcers. Comparison with an anticholinergic drug.

Authors:  C T Richardson; B A Bailey; J H Walsh; J S Fordtran
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

9.  Cimetidine in the treatment of active duodenal and prepyloric ulcers.

Authors:  G Bodemar; A Walan
Journal:  Lancet       Date:  1976-07-24       Impact factor: 79.321

10.  Cimetidine in duodenal ulcer. Controlled trial.

Authors:  W S Blackwood; D P Maudgal; R G Pickard; D Lawrence; T C Northfield
Journal:  Lancet       Date:  1976-07-24       Impact factor: 79.321

View more
  2 in total

1.  Release of cholecystokinin and exocrine pancreatic secretion in response to an elemental diet in human subjects.

Authors:  S Watanabe; K Shiratori; T Takeuchi; W Y Chey; C H You; T M Chang
Journal:  Dig Dis Sci       Date:  1986-09       Impact factor: 3.199

2.  Postprandial biliary and pancreatic secretion during profound inhibition of gastric secretion in humans.

Authors:  A Lanzini; D Facchinetti; M G Pigozzi; A Wuhrer; A Saleri
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.